Back to results
US 2018/0228748 A1Published application
Inhibitors and methods of inhibiting bacterial and viral pathogens
AssigneeSiga Technologies, Inc.
InventorsRobert D. ALLEN, III, Sean M. AMBERG, Dongcheng DAI, James R. BURGESON, Dennis E. HRUBY
Life of this patent
Estimating the term…
Abstract
Compounds, pharmaceutical compositions and methods for treating viral and bacterial infections, by administering certain thiourea compounds, specifically acylthiourea, carboximidoylthiourea and S-alkyl isothiourea derivatives and analogs, in therapeutically effective amounts are disclosed.
Claims35
1-12. (canceled)
A method for the treatment or prophylaxis of a viral or bacterial infection or disease associated therewith, wherein the viral infection is caused by a virus family selected from the group consisting of:
- Bunyaviridae, Poxviridae, Arenaviridae, Picornaviridae, Togaviridae, Flaviviridae, Filoviridae, Paramyxoviridae, Orthomyxoviridae and Retroviridae, comprising administering in a therapeutically effective amount to a mammal in need thereof, a compound of Formula I below or a pharmaceutically acceptable salt thereof:
- wherein R1 is selected from the group consisting of:
- H, chloro, methyl, methoxy, ethoxy, nitro and fluoro;
- R2 is selected from the group consisting of:
- H, chloro, methyl, methoxy, trifluoromethyl, propanoylamino and 2-methylpropanoylamino;
- R3 is selected from the group consisting of:
- H, methyl, amino, methylamino, dimethylamino, phenylamino and 3-pyridylamino;
- R4 is selected from the group consisting of:
- H, chloro, methyl, methoxy, trifluoromethyl and trifluoromethoxy;
- and
- R5 is selected from the group consisting of H and methyl.
8 more elements
(canceled)
46-175. (canceled)
Dependencies are inferred from the claim text.